Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.085 | 0.08 |
mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.079 | 0.09 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.079 | 0.1 |
mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.071 | 0.2 |
mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.076 | 0.2 |
mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.065 | 0.2 |
mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.07 | 0.2 |
mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.064 | 0.2 |